{' '} {' '}
Limited time offer
SAVE % on your upgrade.

Page 1

FO

R

S

E L A

Kalundborg, Denmark

MODERN, HIGH QUALITY PHARMA INGREDIENTS FACILITY CLOSED PRODUCTION SYSTEM | STANDALONE SITE ~50,000m2 grounds | ~15,000m2 total building area ~9,000m2 production & storage areas | ~6,000m2 office, laboratory, control room, workshop, canteen, etc.


ZEALAND, DENMARK

EUROPE

MAJOR PHARMA & INDUSTRIAL CLUSTER ________

COPENHAGEN KALUNDBORG

Kalundborg is located right in the center of Northern Europe and at the entrance to the Baltic Sea

Diverse transportation infrastructure; Deep-water port with tank and container terminals next door Copenhagen International Airport (~1hr) Bridge connection to Sweden, Malmö/Lund (~1½ hrs)

Companies located in the area enjoy symbiosis and synergy effects from the largest Pharma & Industrial cluster and Ecosystem in Denmark

Neighbouring companies include Novo Nordisk, Novozymes, Equinor, National Oilwell Varco, Saint-Gobain, etc.

Large qualified labor pool available locally. Both academics and process operators

Strong support from local authorities for the companies in the industry cluster

Motorways Highways Industrial ports Capital city

Deep-water port

Source: Kalundborg Symbiosis


KEY FACTS ________ Area m2 Office, laboratory, etc.

6,112

Production and storage

9,694

Land area

50,322

Year of construction

2009

Previous established

GMP for APIs (ICH Q7)

Quality Standard

(Inspected/approved by e.g. FDA & Danish

STATE OF THE ART PRODUCTION FACILITIES ________ ➔

Highly automated pharma ingredients manufacturing facility built by Pronova BioPharma

Engineered by a leading pharma engineering company NNE Pharmaplan

Closed Production System including CIP. Up to 18 meter ceiling heights for flexible usage

Constructed in 2009 to high quality standards, at a cost of ~250m Euro

Broad machinery capability: Bleaching, deacidification, separation, mixing & drumming, transesterification, distillation, stripping, etc.

Comprehensive on-site utilities including own wastewater treatment plant

Total, on-site tank capacity 2,500m3. Additional tank capacity for lease at the centralized Kalundborg Tank Terminal (connected via underground pipeline)

Modern office, laboratory, canteen, and admin. building with emphasis on employee wellbeing

Ample expansion opportunities: land included is prepared for expansion of production facilities. Further, developed land is available both adjacent and in the newly annexed Northern port area

Competitive, transferable leasehold until 2056

Production has temporarily been shut down and kept in ‘ready now’ stage and maintained for a quick restart

Medicines Agency)

Owner

BASF

Previous use

Omega-3 API

Example alternative usage

Oil processing, Oil refinement, Pharma, BioFuel, Cosmetics, Food/Beverage, Aroma, etc.

BASF is selling the asset - all bidders welcome! Planned Timeline: Express interest by : end February 2020 Indicative bids by : end March 2020


This material is confidential and meant for professional investors only. It may not be distributed to outsiders without written permission from BASF A/S. No warranty, responsibility or liability is accepted by BASF A/S or TrueMarketValue as to the accuracy or completeness of this material.

CONTACT True-Market-Value.com

Allan Kehlet Rieck, Allan@TrueMarketValue.dk, +45 21 79 01 59 Martin Schrøder, Martin@TrueMarketValue.dk, +45 22 88 02 20

Profile for TrueMarketValue

MODERN, HIGH QUALITY PHARMA INGREDIENTS FACILITY - TEASER  

CLOSED PRODUCTION SYSTEM | STAND ALONE SITE ~50,000m2 grounds | ~15,000m2 total building area ~9,000m2 production & storage areas | ~6,000m...

MODERN, HIGH QUALITY PHARMA INGREDIENTS FACILITY - TEASER  

CLOSED PRODUCTION SYSTEM | STAND ALONE SITE ~50,000m2 grounds | ~15,000m2 total building area ~9,000m2 production & storage areas | ~6,000m...